Navigation Links
Gender May Influence Heart Failure Treatment
Date:1/22/2009

Care varies for men and women, and by male and female doctors, study finds

THURSDAY, Jan. 22 (HealthDay News) -- Drug treatment for heart failure is influenced by the gender of the patient and the doctor, according to German researchers who evaluated 1,857 patients and the treatment records of 829 physicians.

The study found that female patients were less likely to receive guideline-recommended medications, such as angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs) and beta blockers. Women also received lower doses than men, the study found.

And, drug treatment was more complete, the researchers said, when patients received care from a female doctor.

The use of ACE inhibitors and ARBs was lower in female patients treated by male doctors than in male patients treated by either female or male doctors. The dose of ACE inhibitors and ARBs was highest in male patients treated by female doctors and was lower in female patients treated by male doctors. Use of beta blockers in male patients was not affected by the doctor's gender, but female patients treated by male doctors received lower doses of beta blockers than did male patients.

The findings were published in the European Journal of Heart Failure.

"The use of evidence-based treatments as described in the latest guidelines has undoubtedly improved the treatment of chronic heart failure," Dr. Magnus Baumhäkel, of the University Hospital of the Saarland in Homburg, Germany, and a study author, said in a European Society of Cardiology news release. "But there is still evidence of a gender imbalance in both patients and physicians. From our results, it seems fair to say that the gender of the physician plays an important role in adherence to drug treatment recommendations in chronic heart failure."

A number of recent studies have identified gender differences in medical care and survival among people with cardiovascular disease. Many of the studies found that women are treated less intensively than men, especially in the acute phase of the disease.

More information

The American Heart Association has more about medicines used to treat heart failure.



-- Robert Preidt



SOURCE: European Society of Cardiology, news release, Jan. 21, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. An ESC statement on gender differences in medical care and survival after myocardial infarction
2. Kimberly-Clark Introduces New Depend Underwear for Men & Women; Unveils Brands First Gender-Specific Adult Absorbent Underwear
3. Psychologists report that a gender gap in spatial skills starts in infancy
4. Gender is key factor in determining overall survival of lung cancer patients
5. Gender Matches Benefit Heart Transplants
6. Gender affects perceptions of infidelity
7. Gender is a relative term in politics, MU study finds
8. UNC receives record $181 million grant to evaluate health, poverty and gender programs worldwide
9. APA resolves to play leading role in improving treatment for gender-variant people
10. Alcohols Impact on Heart, Stroke Risk Differs by Gender
11. Gender Plays Role in Post-Concussion Healing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gender May Influence Heart Failure Treatment
(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” Pate ... year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children ... those children. James saw firsthand the effect of the critical funding gap for research ...
(Date:1/19/2017)... ... January 19, 2017 , ... Connecticut Dermatology Group (CDG) ... a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background in ... “It is with considerable pleasure to welcome back Dr. Kim to the CDG team” ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... From a ... are released almost daily linking gut health to chronic disease, mental health and general ... Year ” as an important resolution to consider. , For one Charlottesville restaurant, good ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced ... to compete in the Boston Marathon on April 17. From first-time participants to ... marathon to join Team V and support the Foundation’s mission to declare victory over ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)...   Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to restore ... the Company,s operating results for 2016 and an outline ... Company described in its recent 10-K filing with the ... The Company,s contract laboratory completed its evaluation of NovaDerm®, ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: